Evernest Financial Advisors LLC purchased a new stake in shares of LENSAR, Inc. (NASDAQ:LNSR – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 19,500 shares of the company’s stock, valued at approximately $174,000.
Separately, Sanctuary Advisors LLC bought a new stake in shares of LENSAR in the 2nd quarter valued at about $93,000. 40.15% of the stock is owned by hedge funds and other institutional investors.
LENSAR Price Performance
LNSR opened at $11.10 on Friday. The stock’s 50 day simple moving average is $8.39 and its 200 day simple moving average is $6.27. The firm has a market cap of $128.87 million, a price-to-earnings ratio of -7.60 and a beta of 0.63. LENSAR, Inc. has a 1 year low of $2.67 and a 1 year high of $11.90.
About LENSAR
LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.
Featured Stories
- Five stocks we like better than LENSAR
- 3 Fintech Stocks With Good 2021 Prospects
- Nebius Group: Market Overreaction or Real AI Disruption?
- Consumer Staples Stocks, Explained
- The Best Way to Invest in Gold Is…
- Insider Trades May Not Tell You What You Think
- Why Nike Stock Could Be 2025’s Top Comeback Play
Want to see what other hedge funds are holding LNSR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LENSAR, Inc. (NASDAQ:LNSR – Free Report).
Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.